🚀 VC round data is live in beta, check it out!
DanCann Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for DanCann Pharma and similar public comparables like Itoco, Neovacs, bioXXmed, Lipigon Pharmaceuticals and more.
DanCann Pharma Overview
About DanCann Pharma
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
Founded
2018
HQ
Employees
5
Website
Sectors
Financials (FY)
EV
$12K
DanCann Pharma Stock Performance
DanCann Pharma has current market cap of $90K, and enterprise value of $12K.
DanCann Pharma's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12K | $90K | (14.7%) | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDanCann Pharma Valuation Multiples
DanCann Pharma Financial Valuation Multiples
As of March 11, 2026, DanCann Pharma has market cap of $90K and EV of $12K.
Equity research analysts estimate DanCann Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $90K | XXX | $90K | XXX | XXX | XXX |
| EV (current) | $12K | XXX | $12K | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DanCann Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
DanCann Pharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Itoco | XXX | XXX | XXX | XXX | XXX | XXX |
| Neovacs | XXX | XXX | XXX | XXX | XXX | XXX |
| bioXXmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Lipigon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Lidds | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DanCann Pharma M&A Activity
DanCann Pharma acquired XXX companies to date.
Last acquisition by DanCann Pharma was on XXXXXXXX, XXXXX. DanCann Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DanCann Pharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDanCann Pharma Investment Activity
DanCann Pharma invested in XXX companies to date.
DanCann Pharma made its latest investment on XXXXXXXX, XXXXX. DanCann Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DanCann Pharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DanCann Pharma
| When was DanCann Pharma founded? | DanCann Pharma was founded in 2018. |
| Where is DanCann Pharma headquartered? | DanCann Pharma is headquartered in Denmark. |
| How many employees does DanCann Pharma have? | As of today, DanCann Pharma has over 5 employees. |
| Is DanCann Pharma publicly listed? | Yes, DanCann Pharma is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of DanCann Pharma? | DanCann Pharma trades under DANCAN ticker. |
| When did DanCann Pharma go public? | DanCann Pharma went public in 2020. |
| Who are competitors of DanCann Pharma? | DanCann Pharma main competitors are Itoco, Neovacs, bioXXmed, Lipigon Pharmaceuticals. |
| What is the current market cap of DanCann Pharma? | DanCann Pharma's current market cap is $90K. |
| Is DanCann Pharma profitable? | No, DanCann Pharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.